Trio Pharmaceuticals: Funding, Investors & Team (Oct 2026)
Trio Pharmaceuticals is a cancer therapeutics company that develops dual-action drugs for immunogenic tumors. These drugs directly stop tumor growth and selectively stop immunosuppression in the tumor without targeting the current immune checkpoint pathways. The company was founded in 2018 and is headquartered in San Diego, California.
Trio Pharmaceuticals has raised $4.6M across 2 funding rounds on record, the most recent a Seed of $3.1M announced in Dec 2024.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Trio Pharmaceuticals Company Profile and Key Stats
Latest funding round on record: Dec 2024.
Trio Pharmaceuticals Funding Rounds
Trio Pharmaceuticals raised $1.5M in an undisclosed round announced in Nov 2022.
2.1 years later, a Seed of $3.1M was announced in Dec 2024.
Trio Pharmaceuticals Founders and Leadership Team
Contact details for the Trio Pharmaceuticals team: 2 of 2 have an email address on file.
Start 14-day free trial →Trio Pharmaceuticals Funding Compared to Other Biotechnology Startups
Trio Pharmaceuticals' latest round of $3.1M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Trio Pharmaceuticals in Biotechnology and San Diego
Companies Similar to Trio Pharmaceuticals
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Trio Pharmaceuticals Funding FAQs
What does Trio Pharmaceuticals do?
Trio Pharmaceuticals is a cancer therapeutics company that develops dual-action drugs for immunogenic tumors. These drugs directly stop tumor growth and selectively stop immunosuppression in the tumor without targeting the current immune checkpoint pathways. The company was founded in 2018 and is headquartered in San Diego, California.
How much funding has Trio Pharmaceuticals raised?
Trio Pharmaceuticals has raised $4.6M across 2 rounds on record. The most recent is a Seed of $3.1M announced in Dec 2024.
When did Trio Pharmaceuticals last raise funding?
Trio Pharmaceuticals' most recent funding round on record is a Seed of $3.1M, announced in Dec 2024.
Who founded Trio Pharmaceuticals?
FundedIQ lists Shiva Bhowmik (Founder) at Trio Pharmaceuticals.
Who is the CEO of Trio Pharmaceuticals?
Reiner Laus is listed as CEO at Trio Pharmaceuticals.
Where is Trio Pharmaceuticals headquartered?
Trio Pharmaceuticals is based in San Diego, California, United States.
How many employees does Trio Pharmaceuticals have?
Trio Pharmaceuticals is in the 1-10 employee band.
How does Trio Pharmaceuticals' funding compare to other Biotechnology startups?
Trio Pharmaceuticals' latest round of $3.1M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Trio Pharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Trio Pharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.